Synthetic implant company Cartiva closed a $4.3 million financing round led by venture capital firm New Enterprise Associates. As part of the round, 1 of the VC firm's partners, Dr. Justin Klein, will join Cartiva's board of directors. The Alpharetta, Ga.-based device maker plans to use the funds to support trials for its synthetic cartilage implant for treatment of arthritis in the big toe.
Cell therapies may stop or reverse the pain and disability of degenerative disc disease and the loss of material between vertebrae, according to Duke University scientists. The health conditions affect thousands of Americans.
AlignMed, the innovative developer of wellness wear that has been scientifically proven to reduce pain and improve posture, has received FDA Registration for its line of breakthrough specialty garments. AlignMed products are in an elite category of garments approved by the FDA Registration process as a Class 1 Medical Device.
Ceterix Orthopaedics has announced commercial availability of the company’s NovoStitch suture passer in the United States. The company’s device enables surgeons to place stitches in tight joint compartments, including those in knees, hips, and shoulders, during minimally invasive arthroscopic surgical procedures.
ulrich medical USA, Inc., today announced the U.S. market release of the uCerv Interbody System which is a spinal implant device used for anterior cervical discectomy and fusion (ACDF) surgical procedures (C2-C7). The uCerv System consists of trapezoidal shaped implants that are available in a parallel or lordotic configuration of various heights.
Misonix announced today that it has received the necessary Registration Certificate from the State Food and Drug Administration (SFDA) of the People's Republic of China (PRC) to market and sell its BoneScalpel (Ultrasonic Osteotome System) product in China.
A natural tissue graft can spur regeneration of cartilage and improve symptoms in patients who have cartilage damage in their knee, according to a study by researchers from Hospital for Special Surgery. The new research, the first case-series evaluation of De Novo NT Natural Tissue Graft, will be presented at the annual meeting of the American Orthopaedic Society for Sports Medicine.
Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, announced today that it has been awarded four new patents in 2013 from the U.S. Patent and Trademark Office. These patents relate to Titan’s unique implant surface technology, as well as the design of its Endoskeleton ® interbody device and specialized system instrumentation.
Mitek Sports Medicine*, a leader in orthopaedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of the HEALIX ADVANCE™ KNOTLESS Anchor, a new suture anchor designed to provide optimal knotless fixation for rotator cuff repair.
Doctors have a new way of thinking about how to treat heart and skeletal muscle diseases. Body builders have a new way of thinking about how they maximize their power. Both owe their new insight to high-energy X-rays, a moth and cloud computing.
Researchers at the University of Southampton have completed a project that will enable surgeons to fit joint replacements with longer, optimised lifespans. The MXL project uses computational modelling to define the mechanics of an artificial joint to ensure successful surgery and longer lifespans of the prosthetic joints.
Orthocare Innovations continues receiving critical acclaim as its Magellan microprocessor foot ankle system has been named one of the Top 100 technologically significant products introduced into the marketplace over the past year. In selecting Orthocare Innovations for its R&D Top 100 Awards, R&D Magazine placed it in elite company that includes Lawrence Berkeley National Laboratory and Toyota.
On this episode of The Pulse, a device that helps train the brain to turn sounds into images, detecting cancer by imaging the consumption of sugar, biomedical applications for a new hydrogel, and a nanofiber mesh that treats tumors with both thermotherapy and chemotherapy.
With Zimmer still reeling from a 10% slide in its spine business, the orthopedic device maker announced a deal with SpineCraft, maker of the Apex spine correction device. The long-term distribution deal allows Zimmer Spine to market Apex in the U.S., Canada, New Zealand and Australia, according to a press release.
Spinal Elements, a spine technology company, today announced that spine surgeon Scott H. Kitchel, MD of Eugene, Oregon recently presented data on the company's Ti-Bond® porous titanium coated polyetheretherketone (PEEK) interbody devices at the Spine Technology and Educational Group meeting held June 20-22 in Los Cabos, Mexico.
Aesculap Implant Systems announced today the availability of the new Quintex Anterior Cervical Plating System, today’s most versatile system for use in ACDF procedures at multiple levels from C2-T1. Quintex was designed to address all plating ideologies and offers construct options ranging from fully rigid to dynamic, including the new Semidynamic™ option, unique to Aesculap Implant Systems’.
Dr. Jie Zheng and Dr. Robert Weiss are among the most recent to contribute to the growing research of hydrogels, the gelatinous substance that, because of its toughness and plasticity, has several biomedical applications, including cartilage repair, implants for minimally invasive surgery and drug delivery.
North Carolina medical device maker Baxano Surgical Inc. (NSDQ:BAXS) agreed to pay $6 million to close a Justice Dept. probe initiated nearly 2 years ago. The definitive settlement consummates a tentative agreement the spinal device company forged with federal regulators in December 2012, according to a Baxano Surgical statement.
Bioventus, a global leader in active orthopaedic healing, today unveiled the next generation of its market-leading 1 EXOGEN ® Ultrasound Bone Healing System. The new EXOGEN has begun shipping in Europe and will be released in the United States, Canada and Australia later this year.
Medtronic (NYSE:MDT) prevailed in an antitrust lawsuit filed over a bone mill made by Lenox MacLaren Surgical, with a federal judge ruling that Lenox misrepresented the size of the bone mill market and failed to adequately market its own device.
Some 55 U.S. hospitals agreed to pay a total of $34 million to settle U.S. Justice Dept. charges that they overcharged Medicare for Medtronic's (NYSE:MDT)'s kyphoplasty spine procedure, acquired in the $3.9 billion buyout of Kyphon in 2007, the Justice Dept. said today.
Minnesota medical device giant Medtronic (NYSE:MDT) confirmed today that it recalled certain of its already-troubled Infuse spinal fusion surgery kits after learning of possible contamination in sponges manufactured by Integra Lifesciences.
SpineGuard announced today that it has obtained regulatory clearance from COFEPRIS (the Mexican healthcare regulatory authority) to sell its Cannulated PediGuard® device in Mexico. SpineGuard has previously received clearance for its Classic PediGuard device, and over 50 Mexican spine surgeons have been trained on the technology.
A study by researchers at Hospital for Special Surgery has provided the first evidence that the shape of a person's knee could be a factor in the decision of whether a patient should undergo anterior cruciate ligament reconstruction after an ACL tear.
As more therapies are able to indicate implantable devices for treatment, incorporating drug delivery into them can be a significant additional benefit. Even when drug delivery is the primary function, implantable devices can be preferable. This article reviews some representative applications that device designers can leverage in developing new products for the implantable drug delivery market.